UVB therapy of pityriasis lichenoides--our experience with 29 patients

J Eur Acad Dermatol Venereol. 2006 May;20(5):542-7. doi: 10.1111/j.1468-3083.2006.01531.x.

Abstract

Background: Pityriasis lichenoides comprises a clinical and pathological spectrum of disorders. So far no highly effective treatment has been reported. Previous small studies have suggested that ultraviolet B (UVB) is a good alternative.

Methods: This is a retrospective analysis of 29 pityriasis lichenoides patients treated in our institution with broad- or narrow-band UVB during the period 1996-2002. Twenty-one of these patients had one or more previous unsuccessful treatments.

Results: Complete response was achieved in 93.1% in both treatment groups, with 73% of them still relapse free after a mean follow-up of 58 and 38 months in broad- and narrow-band UVB treatment groups, respectively. Mild side-effects were observed in about one-third of the patients.

Conclusion: We believe both forms of UVB are a good option for pityriasis lichenoides and should be considered as the first line in generalized cases interested in treatment.

MeSH terms

  • Adult
  • Chi-Square Distribution
  • Female
  • Humans
  • Logistic Models
  • Male
  • Pityriasis Lichenoides / radiotherapy*
  • Recurrence
  • Retrospective Studies
  • Treatment Outcome
  • Ultraviolet Therapy / adverse effects
  • Ultraviolet Therapy / methods*